Nicholas Chadi1, Guilin Li, Natalie Cerda, Elissa R Weitzman. 1. Adolescent Substance Use and Addiction Program, Division of Developmental Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA (NC); Harvard Chan School of Public Health, Harvard University, Boston, MA (NC, GL); Developmental Medicine Center, Division of Developmental Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA (NC); Division of Adolescent and Young Adult Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA (ERW).
Abstract
OBJECTIVES: E-cigarette use has increased dramatically among adolescents in the past 5 years alongside a steady increase in daily use of marijuana. This period coincides with a historic rise in depression and suicidal ideation among adolescents. In this study, we describe the associations between e-cigarette and marijuana use and depressive symptoms and suicidality in a large nationally representative sample of high school students. METHODS: We used data from the 2 most recent waves (2015 and 2017) of the Youth Risk Behavior Survey. Our sample (n = 26,821) included only participants with complete information for age, sex, race/ethnicity, and exposure to e-cigarettes and marijuana (89.5% of survey respondents). We performed multivariate logistic regressions to explore the associations between single or dual use of e-cigarette and marijuana and depressive and suicidal symptoms in the past year adjusting for relevant confounders. RESULTS: E-cigarette-only use was reported in 9.1% of participants, marijuana-only use in 9.7%, and dual e-cigarette/marijuana use in 10.2%. E-cigarette-only use (vs no use) was associated with increased odds of reporting suicidal ideation (adjusted odds ratio [AOR]:1.23, 95% CI 1.03-1.47) and depressive symptoms (AOR: 1.37, 95% CI 1.19-1.57), which was also observed with marijuana-only use (AOR: 1.25, 95% CI 1.04-1.50 and AOR: 1.49, 95% CI 1.27-1.75) and dual use (AOR: 1.28, 95% CI 1.06-1.54 and AOR: 1.62, 95% CI 1.39-1.88). CONCLUSIONS: Youth with single and dual e-cigarette and marijuana use had increased odds of reporting depressive symptoms and suicidality compared to youth who denied use. There is a need for effective prevention and intervention strategies to help mitigate adverse mental health outcomes in this population.
OBJECTIVES: E-cigarette use has increased dramatically among adolescents in the past 5 years alongside a steady increase in daily use of marijuana. This period coincides with a historic rise in depression and suicidal ideation among adolescents. In this study, we describe the associations between e-cigarette and marijuana use and depressive symptoms and suicidality in a large nationally representative sample of high school students. METHODS: We used data from the 2 most recent waves (2015 and 2017) of the Youth Risk Behavior Survey. Our sample (n = 26,821) included only participants with complete information for age, sex, race/ethnicity, and exposure to e-cigarettes and marijuana (89.5% of survey respondents). We performed multivariate logistic regressions to explore the associations between single or dual use of e-cigarette and marijuana and depressive and suicidal symptoms in the past year adjusting for relevant confounders. RESULTS: E-cigarette-only use was reported in 9.1% of participants, marijuana-only use in 9.7%, and dual e-cigarette/marijuana use in 10.2%. E-cigarette-only use (vs no use) was associated with increased odds of reporting suicidal ideation (adjusted odds ratio [AOR]:1.23, 95% CI 1.03-1.47) and depressive symptoms (AOR: 1.37, 95% CI 1.19-1.57), which was also observed with marijuana-only use (AOR: 1.25, 95% CI 1.04-1.50 and AOR: 1.49, 95% CI 1.27-1.75) and dual use (AOR: 1.28, 95% CI 1.06-1.54 and AOR: 1.62, 95% CI 1.39-1.88). CONCLUSIONS: Youth with single and dual e-cigarette and marijuana use had increased odds of reporting depressive symptoms and suicidality compared to youth who denied use. There is a need for effective prevention and intervention strategies to help mitigate adverse mental health outcomes in this population.
Authors: Philip Baiden; Hannah S Szlyk; Patricia Cavazos-Rehg; Henry K Onyeaka; JaNiene E Peoples; Erin Kasson Journal: J Psychiatr Res Date: 2021-12-22 Impact factor: 5.250
Authors: Nathaniel M Lewis; Michael Friedrichs; Shelly S Wagstaff; Allyn K Nakashima; Angela C Dunn Journal: Public Health Rep Date: 2021-05-26 Impact factor: 3.117
Authors: Nkiruka C Atuegwu; Cheryl Oncken; Reinhard C Laubenbacher; Mario F Perez; Eric M Mortensen Journal: Int J Environ Res Public Health Date: 2020-10-05 Impact factor: 3.390